{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:55:57Z","timestamp":1790193357301,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijantimicag.2025.107527","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:15:33Z","timestamp":1745867733000},"page":"107527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A review of recently discovered mechanisms of cephalosporin resistance in Pseudomonas aeruginosa"],"prefix":"10.1016","volume":"66","author":[{"given":"Madeleine T.","family":"Hardie Boys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5750-7505","authenticated-orcid":false,"given":"Daniel","family":"Pletzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107527_bib0001","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11274-019-2739-1","article-title":"Metabolomic studies of Pseudomonas aeruginosa","volume":"35","author":"Mielko","year":"2019","journal-title":"World J Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0002","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12890-016-0339-5","article-title":"Cystic fibrosis lung environment and Pseudomonas aeruginosa infection","volume":"16","author":"Bhagirath","year":"2016","journal-title":"BMC Pulmonary Med"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0003","doi-asserted-by":"crossref","first-page":"8248","DOI":"10.1021\/acsabm.1c00794","article-title":"Preventing Pseudomonas aeruginosa biofilms on indwelling catheters by surface-bound enzymes","volume":"4","author":"Asker","year":"2021","journal-title":"ACS Appl Bio Materials"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0004","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.3390\/ijms21228671","article-title":"Pseudomonas aeruginosa biofilms","volume":"21","author":"Thi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.07.003","article-title":"WHO publishes updated list of bacterial priority pathogens","volume":"5","author":"Jesudason","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0006","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm Ther"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2022.104950","article-title":"Therapeutic approaches for combating Pseudomonas aeruginosa infections","volume":"24","author":"Jangra","year":"2022","journal-title":"Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0008","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3390\/pathogens10121638","article-title":"Beta-lactam resistance in Pseudomonas aeruginosa: current status, future prospects","volume":"10","author":"Glen","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415779","article-title":"Role of efflux pumps on antimicrobial resistance in Pseudomonas aeruginosa","volume":"23","author":"Lorusso","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00089-21","article-title":"Emergence of resistance to novel cephalosporin-beta-lactamase inhibitor combinations through the modification of the Pseudomonas aeruginosa MexCD-OprJ efflux pump","volume":"65","author":"Gomis-Font","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0011","article-title":"Molecular mechanism of the beta-lactamase mediated beta-lactam antibiotic resistance of Pseudomonas aeruginosa isolated from a Chinese teaching hospital","volume":"13","author":"Lin","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0012","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3947\/ic.2015.47.2.81","article-title":"Epidemiology and characteristics of metallo-beta-lactamase-producing Pseudomonas aeruginosa","volume":"47","author":"Hong","year":"2015","journal-title":"Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0013","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41429-023-00687-y","article-title":"Cephalosporin resistance, tolerance, and approaches to improve their activities","volume":"77","author":"Araten","year":"2024","journal-title":"J Antibiotics (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0014","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025247","article-title":"Beta-lactams and beta-lactamase inhibitors: an overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4062\/biomolther.2023.008","article-title":"Structural insights for beta-lactam antibiotics","volume":"31","author":"Kim","year":"2023","journal-title":"Biomolec Ther (Seoul)"},{"issue":"Suppl 1)","key":"10.1016\/j.ijantimicag.2025.107527_bib0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.37201\/req\/s01.12.2021","article-title":"Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria","volume":"34","author":"Silva","year":"2021","journal-title":"Rev Espan Quimioter"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0017","doi-asserted-by":"crossref","first-page":"52","DOI":"10.29074\/ascls.24.1.52","article-title":"Treatment strategies and recommendations for Pseudomonas aeruginosa infections","volume":"24","author":"Moore","year":"2011","journal-title":"Am Soc Clin Lab Sci"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0018","series-title":"Cephalosporins","author":"Bui","year":"2023"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0019","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/B978-1-4557-4801-3.00021-7","article-title":"Cephalosporins","author":"Craig","year":"2015","journal-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0020","doi-asserted-by":"crossref","DOI":"10.37897\/RJPhP.2020.3.2","article-title":"The new fifth-generation cephalosporins\u2014a balance between safety and efficacy","volume":"13","author":"Rusu","year":"2020","journal-title":"Romanian Journal of Pharmaceutical Practice"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0021","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1128\/AAC.01666-15","article-title":"Daptomycin in combination with ceftolozane-tazobactam or cefazolin against daptomycin-susceptible and -nonsusceptible Staphylococcus aureus in an in vitro, hollow-fiber model","volume":"60","author":"Smith","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0022","doi-asserted-by":"crossref","first-page":"e02085","DOI":"10.1128\/mBio.02085-18","article-title":"Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in Pseudomonas aeruginosa","volume":"9","author":"Barnes","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0023","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1128\/AAC.02365-12","article-title":"Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections","volume":"57","author":"Bauer","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258359","article-title":"Structural analysis of the boronic acid beta-lactamase inhibitor vaborbactam binding to Pseudomonas aeruginosa penicillin-binding protein 3","volume":"16","author":"Kumar","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.15537\/smj.2022.43.1.20210587","article-title":"The antimicrobial activity of ceftobiprole against Methicillin-resistant Staphylococcus aureus and multi-drug resistant Pseudomonas aeruginosa: a large tertiary care university hospital experience in Riyadh, Saudi Arabia","volume":"43","author":"Altamimi","year":"2022","journal-title":"Saudi Med J"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0026","doi-asserted-by":"crossref","first-page":"e00951","DOI":"10.1128\/JCM.00951-20","article-title":"Cefiderocol antimicrobial susceptibility testing considerations: the Achilles' heel of the Trojan horse?","volume":"59","author":"Simner","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01009-23","article-title":"The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy","volume":"68","author":"Teran","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0028","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1093\/cid\/ciaa1799","article-title":"US Food and Drug Administration (FDA): benefit-risk considerations for cefiderocol (Fetroja(R))","volume":"72","author":"Naseer","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0029","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s40121-021-00412-y","article-title":"Cost analysis of new antibiotics to treat multidrug-resistant bacterial infections: mind the gap","volume":"10","author":"Yahav","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/1471-2180-10-328","article-title":"Pseudomonas aeruginosa beta-lactamase induction requires two permeases, AmpG and AmpP","volume":"10","author":"Kong","year":"2010","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0031","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/AAC.01807-15","article-title":"Characterization of a carbapenem-hydrolyzing enzyme, PoxB, in Pseudomonas aeruginosa PAO1","volume":"60","author":"Zincke","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0032","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40560-020-0429-6","article-title":"Molecular diversity of extended-spectrum beta-lactamases and carbapenemases, and antimicrobial resistance","volume":"8","author":"Sawa","year":"2020","journal-title":"J Intens Care"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0033","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01771-20","article-title":"Redox protein OsaR (PA0056) regulates dsbM and the oxidative stress response in Pseudomonas aeruginosa","volume":"65","author":"Liu","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0034","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0035","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1128\/AAC.00505-13","article-title":"Structural analysis of the role of Pseudomonas aeruginosa penicillin-binding protein 5 in beta-lactam resistance","volume":"57","author":"Smith","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0036","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1128\/AAC.05150-14","article-title":"Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, beta-lactam resistance, and peptidoglycan structure","volume":"59","author":"Ropy","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0037","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1128\/AAC.02556-14","article-title":"The Pseudomonas aeruginosa CreBC two-component system plays a major role in the response to beta-lactams, fitness, biofilm growth, and global regulation","volume":"58","author":"Zamorano","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000353","article-title":"Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein","volume":"5","author":"Moya","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034067","article-title":"The regulatory repertoire of Pseudomonas aeruginosa AmpC ss-lactamase regulator AmpR includes virulence genes","volume":"7","author":"Balasubramanian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0040","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1074\/jbc.M114.618199","article-title":"The beta-lactamase gene regulator AmpR is a tetramer that recognizes and binds the D-Ala-D-Ala motif of its repressor UDP-N-acetylmuramic acid (MurNAc)-pentapeptide","volume":"290","author":"Vadlamani","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0041","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1021\/jacs.6b12819","article-title":"Muropeptide binding and the x-ray structure of the effector domain of the transcriptional regulator AmpR of Pseudomonas aeruginosa","volume":"139","author":"Dik","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0042","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1128\/JB.01997-14","article-title":"Structural and functional characterization of Pseudomonas aeruginosa global regulator AmpR","volume":"196","author":"Caille","year":"2014","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0043","doi-asserted-by":"crossref","first-page":"e00524","DOI":"10.1128\/msystems.00524-19","article-title":"Regulation of AmpC-driven beta-lactam resistance in Pseudomonas aeruginosa: different pathways, different signaling","volume":"4","author":"Torrens","year":"2019","journal-title":"mSystems"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0044","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/cid\/ciz173","article-title":"Antibacterial Resistance Leadership G. A primer on AmpC beta-lactamases: necessary knowledge for an increasingly multidrug-resistant world","volume":"69","author":"Tamma","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0045","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1128\/AAC.00385-10","article-title":"NagZ inactivation prevents and reverts beta-lactam resistance, driven by AmpD and PBP 4 mutations, in Pseudomonas aeruginosa","volume":"54","author":"Zamorano","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0046","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01419-24","article-title":"A potential space-making role in cell wall biogenesis for SltB1and DacB revealed by a beta-lactamase induction phenotype in Pseudomonas aeruginosa","volume":"15","author":"Gyger","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0047","doi-asserted-by":"crossref","first-page":"e01771","DOI":"10.1128\/AAC.01771-19","article-title":"Identification of drug resistance determinants in a clinical isolate of Pseudomonas aeruginosa by high-density transposon mutagenesis","volume":"64","author":"Sonnabend","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0048","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s42003-023-04609-4","article-title":"YgfB increases beta-lactam resistance in Pseudomonas aeruginosa by counteracting AlpA-mediated ampDh3 expression","volume":"6","author":"Eggers","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0049","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1128\/AAC.49.11.4567-4575.2005","article-title":"Pseudomonas aeruginosa AmpR is a global transcriptional factor that regulates expression of AmpC and PoxB beta-lactamases, proteases, quorum sensing, and other virulence factors","volume":"49","author":"Kong","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0051","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1128\/JB.01296-06","article-title":"Characterization of OpdH, a Pseudomonas aeruginosa porin involved in the uptake of tricarboxylates","volume":"189","author":"Tamber","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0052","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acsinfecdis.8b00149","article-title":"Getting drugs through small pores: exploiting the porins pathway in Pseudomonas aeruginosa","volume":"4","author":"Samanta","year":"2018","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0053","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00249-021-01498-5","article-title":"Towards understanding single-channel characteristics of OccK8 purified from Pseudomonas aeruginosa","volume":"50","author":"Dogan Guzel","year":"2021","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0054","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107644118","article-title":"Outer membrane permeability: antimicrobials and diverse nutrients bypass porins in Pseudomonas aeruginosa","volume":"118","author":"Ude","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0055","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03038-22","article-title":"PBP target profiling by beta-Lactam and beta-lactamase inhibitors in intact Pseudomonas aeruginosa: effects of the intrinsic and acquired resistance determinants on the periplasmic drug availability","volume":"11","author":"Montaner","year":"2023","journal-title":"Microbiol Spectrum"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0056","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1093\/jac\/dkae203","article-title":"Penicillin-binding protein 3 sequence variations reduce susceptibility of Pseudomonas aeruginosa to beta-lactams but inhibit cell division","volume":"79","author":"Glen","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0057","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01651-16","article-title":"Penicillin-binding protein 3 is essential for growth of Pseudomonas aeruginosa","volume":"61","author":"Chen","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285856","article-title":"Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex","volume":"18","author":"Ramsay","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0059","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.cmi.2022.11.014","article-title":"Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"29","author":"Lopez-Causape","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0060","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1128\/JB.183.6.1835-1842.2001","article-title":"The pleiotropic two-component regulatory system PhoP-PhoQ","volume":"183","author":"Groisman","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0061","doi-asserted-by":"crossref","first-page":"e00568","DOI":"10.1128\/JB.00568-16","article-title":"Two isoforms of Clp peptidase in Pseudomonas aeruginosa control distinct aspects of cellular physiology","volume":"199","author":"Hall","year":"2017","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0062","article-title":"In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent beta-lactam\/beta-lactamase inhibitor combinations","volume":"12","author":"Santerre Henriksen","year":"2024","journal-title":"Microbiol Spectrum"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0063","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41429-024-00762-y","article-title":"In vitro resistance development gives insights into molecular resistance mechanisms against cefiderocol","volume":"77","author":"Kriz","year":"2024","journal-title":"J Antibiotics (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0064","doi-asserted-by":"crossref","first-page":"ofab311","DOI":"10.1093\/ofid\/ofab311","article-title":"Cefiderocol activity against clinical Pseudomonas aeruginosa isolates exhibiting ceftolozane-tazobactam resistance","volume":"8","author":"Simner","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0065","doi-asserted-by":"crossref","first-page":"dlad107","DOI":"10.1093\/jacamr\/dlad107","article-title":"In vitro activity of cefiderocol against Pseudomonas aeruginosa demonstrating evolved resistance to novel beta-lactam\/beta-lactamase inhibitors","volume":"5","author":"Shields","year":"2023","journal-title":"JAC Antimicrob Resistance"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0066","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jgar.2023.06.003","article-title":"Rapid development of cefiderocol resistance in a carbapenem-resistant Pseudomonas aeruginosa isolate associated with mutations in the pyoverdine biosynthesis pathway","volume":"34","author":"Brakert","year":"2023","journal-title":"J Global Antimicrob Resistance"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0067","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41564-024-01601-4","article-title":"Siderophores promote cooperative interspecies and intraspecies cross-protection against antibiotics in vitro","volume":"9","author":"Galdino","year":"2024","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0068","doi-asserted-by":"crossref","first-page":"e4472","DOI":"10.1093\/cid\/ciaa1909","article-title":"Evolution of cefiderocol non-susceptibility in Pseudomonas aeruginosa in a patient without previous exposure to the antibiotic","volume":"73","author":"Streling","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0069","doi-asserted-by":"crossref","first-page":"e00097","DOI":"10.1128\/AAC.00097-18","article-title":"TonB-dependent receptor repertoire of Pseudomonas aeruginosa for uptake of siderophore-drug conjugates","volume":"62","author":"Luscher","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0070","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/AAC.05336-11","article-title":"Role of intracellular proteases in the antibiotic resistance, motility, and biofilm formation of Pseudomonas aeruginosa","volume":"56","author":"Fernandez","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0071","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40265-018-0902-x","article-title":"Ceftazidime-avibactam: a review in the treatment of serious gram-negative bacterial infections","volume":"78","author":"Shirley","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0072","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation beta-lactam\/beta-lactamase inhibitor combinations","volume":"63","author":"van Duin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0073","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3390\/antibiotics10080995","article-title":"Old and new beta-lactamase inhibitors: molecular structure, mechanism of action, and clinical use","volume":"10","author":"Carcione","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0074","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1128\/AAC.03057-14","article-title":"Avibactam and class C beta-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance","volume":"58","author":"Lahiri","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0075","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3390\/antibiotics10091126","article-title":"Review of ceftazidime-avibactam for the treatment of infections caused by Pseudomonas aeruginosa","volume":"10","author":"Daikos","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0076","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1352339","article-title":"Using host-mimicking conditions and a murine cutaneous abscess model to identify synergistic antibiotic combinations effective against Pseudomonas aeruginosa","volume":"14","author":"Lyons","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0077","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/antibiotics11050628","article-title":"Resistance to ceftazidime\/avibactam, meropenem\/vaborbactam and imipenem\/relebactam in Gram-negative MDR Bacilli: molecular mechanisms and susceptibility testing","volume":"11","author":"Gaibani","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0078","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00894-20","article-title":"Adding insult to injury: mechanistic basis for how AmpC mutations allow Pseudomonas aeruginosa to accelerate cephalosporin hydrolysis and evade avibactam","volume":"64","author":"Slater","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0079","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00480-23","article-title":"Characterization of Pseudomonas aeruginosa resistance to ceftolozane-tazobactam due to ampC and\/or ampD mutations observed during treatment using semi-mechanistic PKPD modeling","volume":"67","author":"Deroche","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0080","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1128\/AAC.00825-15","article-title":"Mutations in beta-lactamase AmpC increase resistance of Pseudomonas aeruginosa isolates to antipseudomonal cephalosporins","volume":"59","author":"Berrazeg","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0081","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ijantimicag.2018.07.027","article-title":"Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis","volume":"52","author":"Chalhoub","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0082","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/jac\/dkae263","article-title":"Impact of chromosomally encoded resistance mechanisms and transferable beta-lactamases on the activity of cefiderocol and innovative beta-lactam\/beta-lactamase inhibitor combinations against Pseudomonas aeruginosa","volume":"79","author":"Gonzalez-Pinto","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0083","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1128\/AAC.00897-16","article-title":"Interaction of avibactam with class B metallo-beta-lactamases","volume":"60","author":"Abboud","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0084","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/cmdc.202100042","article-title":"Mechanistic investigations of metallo-beta-lactamase inhibitors: strong zinc binding is not required for potent enzyme inhibition","volume":"16","author":"Wade","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0085","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00991-23","article-title":"Relative inhibitory activities of the broad-spectrum beta-lactamase inhibitor xeruborbactam in comparison with taniborbactam against metallo-beta-lactamases produced in Escherichia coli and Pseudomonas aeruginosa","volume":"68","author":"Le Terrier","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0086","article-title":"Biochemical exploration of beta-lactamase inhibitors","volume":"13","author":"Arer","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0087","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00651-22","article-title":"Molecular mechanisms of resistance to ceftazidime\/avibactam in clinical isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American hospitals","volume":"8","author":"Mojica","year":"2023","journal-title":"mSphere"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0088","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1002\/chem.202004694","article-title":"Cephalosporin prodrug inhibitors overcome metallo-beta-lactamase driven antibiotic resistance","volume":"27","author":"van Haren","year":"2021","journal-title":"Chemistry"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0089","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13445","article-title":"Aspergillomarasmine A overcomes metallo-beta-lactamase antibiotic resistance","volume":"510","author":"King","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0090","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.micpath.2019.05.022","article-title":"Impact of specific inhibitors on metallo-beta-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates","volume":"132","author":"Abbas","year":"2019","journal-title":"Microb Pathogen"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0091","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/jac\/dkad200","article-title":"In vitro activity of cefiderocol against MBL-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO-WT surveillance studies (2014-2019)","volume":"78","author":"Takemura","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0092","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00194-23","article-title":"Portsmouth S. Cefiderocol treatment for patients with multidrug- and carbapenem-resistant Pseudomonas aeruginosa infections in the compassionate use program","volume":"67","author":"Satlin","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0093","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01648-19","article-title":"WCK 5222 (cefepime\/zidebactam) pharmacodynamic target analysis against metallo-beta-lactamase producing Enterobacteriaceae in the neutropenic mouse pneumonia model","volume":"63","author":"Lepak","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0094","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1093\/jac\/dkac233","article-title":"Antimicrobial activity of cefepime\/zidebactam (WCK 5222), a beta-lactam\/beta-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19)","volume":"77","author":"Sader","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103491","article-title":"Artificial intelligence as a smart approach to develop antimicrobial drug molecules: A paradigm to combat drug-resistant infections","volume":"28","author":"Talat","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.glmedi.2024.100081","article-title":"Antimicrobial resistance: Impacts, challenges, and future prospects","volume":"2","author":"Ahmed","year":"2024","journal-title":"J Med Surg Public Health"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0097","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10916-024-02089-5","article-title":"From data to decisions: leveraging artificial intelligence and machine learning in combating antimicrobial resistance - a comprehensive review","volume":"48","author":"de la Lastra","year":"2024","journal-title":"J Med Syst"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0098","series-title":"Third-generation cephalosporins","author":"Arumugham","year":"2024"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0099","doi-asserted-by":"crossref","first-page":"8007","DOI":"10.1007\/s00253-022-12272-8","article-title":"Cephalosporins as key lead generation beta-lactam antibiotics","volume":"106","author":"Lin","year":"2022","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0100","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1093\/jac\/dku267","article-title":"Characterization of a novel Zn(2)(+)-dependent intrinsic imipenemase from Pseudomonas aeruginosa","volume":"69","author":"Fajardo","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0101","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/jac\/dkh077","article-title":"Role of the 'cre\/blr-tag' DNA sequence in regulation of gene expression by the Aeromonas hydrophila beta-lactamase regulator, BlrA","volume":"53","author":"Avison","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0102","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/jac\/dkg247","article-title":"Genetic linkage of the penicillinase gene, amp, and blrAB, encoding the regulator of beta-lactamase expression in Aeromonas spp","volume":"51","author":"Niumsup","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0103","doi-asserted-by":"crossref","first-page":"fuad010","DOI":"10.1093\/femsre\/fuad010","article-title":"Bacterial virulence regulation through soluble peptidoglycan fragments sensing and response: knowledge gaps and therapeutic potential","volume":"47","author":"Escobar-Salom","year":"2023","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0104","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1128\/JB.186.17.5672-5684.2004","article-title":"Identification of AlgR-regulated genes in Pseudomonas aeruginosa by use of microarray analysis","volume":"186","author":"Lizewski","year":"2004","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0105","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1038\/s41598-020-60197-x","article-title":"The extracytoplasmic function sigma factor sigma(VreI) is active during infection and contributes to phosphate starvation-induced virulence of Pseudomonas aeruginosa","volume":"10","author":"Otero-Asman","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0106","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00933-20","article-title":"A high-throughput method for identifying novel genes that influence metabolic pathways reveals new iron and heme regulation in Pseudomonas aeruginosa","volume":"6","author":"Glanville","year":"2021","journal-title":"mSystems"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0107","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/IDR.S226687","article-title":"Transcriptome analysis reveals the resistance mechanism of Pseudomonas aeruginosa to tachyplesin I","volume":"13","author":"Hong","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0108","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1099\/jmm.0.001184","article-title":"Extracellular DNA controls expression of Pseudomonas aeruginosa genes involved in nutrient utilization, metal homeostasis, acid pH tolerance and virulence","volume":"69","author":"Lewenza","year":"2020","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0109","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.5897\/AJMR12.2283","article-title":"Identification of genes involved in long-term survival in Pseudomonas aeruginosa PAO1","volume":"6","author":"Kong","year":"2012","journal-title":"Afr J Microbiol Res"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0110","series-title":"Functional characterization of putative beta-lactamases in Pseudomonas aeruginosa","author":"Wilson","year":"2022"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0111","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1073\/pnas.0510501103","article-title":"The crystal structure of SdsA1, an alkylsulfatase from Pseudomonas aeruginosa, defines a third class of sulfatases","volume":"103","author":"Hagelueken","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0112","doi-asserted-by":"crossref","unstructured":"Janet-Maitre M, Job V, Bour M, Brugi\u00e8re S, Robert-Genthon M, Cobessi D, et al. Pseudomonas aeruginosa MipA-MipB envelope proteins act as new sensors of polymyxin. bioRxiv. 2023:2023.08.14.553335.","DOI":"10.1101\/2023.08.14.553335"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0113","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/AAC.48.6.2043-2048.2004","article-title":"Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa","volume":"48","author":"Girlich","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0114","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/CMR.00040-09","article-title":"Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms","volume":"22","author":"Lister","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0115","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/antibiotics12081304","article-title":"The art of war with Pseudomonas aeruginosa: targeting Mex efflux pumps directly to strategically enhance antipseudomonal drug efficacy","volume":"12","author":"Avakh","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2025.107527_bib0116","doi-asserted-by":"crossref","unstructured":"Guenard S, Muller C, Monlezun L, Benas P, Broutin I, Jeannot K, et al. Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2014;58:221\u20138.","DOI":"10.1128\/AAC.01252-13"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:05:40Z","timestamp":1763985940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0924857925000846"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107527","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of recently discovered mechanisms of cephalosporin resistance in Pseudomonas aeruginosa","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107527"}}